Does Aires Work? What the Research Shows

Aires has research reporting favorable physical and biological observations under specific test conditions. The evidence does not establish that every product prevents EMF-related illness or that all study endpoints improved. The useful question is what was tested, what changed, and how confidently the result applies to your intended use.

What is the Aires approach?

Aires develops patterned silicon resonators and describes its approach as modifying aspects of the electromagnetic environment rather than shielding a person from all radiofrequency energy. A proposed field mechanism, a measured biological response and a demonstrated health benefit are separate claims; each needs its own evidence.

Human physiology

The recent Lifetune ONE investigation reports favorable directional observations, alongside nonsignificant principal EEG alpha and HRV comparisons. Its 2024 report and 2025 English manuscript describe one experiment, with some analysis counts and table labels requiring clarification. Two 2015 Havas reports describe individual cases with selected favorable pulse-wave indices and mixed or unchanged outcomes.

Human evidence guide · Original Lifetune ONE report · Havas case 1 · Havas case 2.

Animal and laboratory research

Rat experiments report lower chromosome-aberration frequencies in selected resonator conditions. A 2025 rat report describes selected behavioral and blood findings, with null results and design limitations. Honeybee work examines behavior and gene expression. These studies can support biological hypotheses, but they do not establish the size of a human health benefit.

Biological evidence guide · 2019 rat paper · 2025 rat report.

Physics and modeling

A Springer conference paper models a patterned semiconductor wafer’s electromagnetic response. It is a contribution to the proposed physical explanation, not a clinical efficacy trial. Its DOI is 10.1007/978-981-19-1607-6_7; it is not a 2025 Sensors paper. Patents likewise document intellectual property, not medical approval.

Read the simulation summary · Original paper.

How strong is the overall case?

The program spans several kinds of evidence. Its value is best evaluated study by study, with original documents and unfavorable or null findings visible. Counting reports, translations, manuscripts, reviews and patents together as independent studies overstates replication. “Every result is positive” is not an accurate description of the record.

The next evidence priorities are clear protocols, reconciled datasets, prespecified endpoints, transparent funding and sponsor roles, and independent replication in the populations and devices relevant to customers. The original-source evidence library makes the current source material available for that assessment. Submission of evidence to a public agency is not agency endorsement.

Choosing an Aires product

If you are comparing approaches, first review the evidence for the product and setting you intend to use. Then consult the current product specifications and options. Personal experiences can be useful, but they do not replace controlled research or medical evaluation of persistent symptoms.

Sources and disclosure

This is an Aires editorial summary. Aires sells the products discussed and has a commercial interest in the research. Institutional affiliation, an external author, or a third-party opinion alone does not establish financial independence. Where a linked report does not establish funding or the sponsor’s role, those details remain unconfirmed. Original researchers retain authorship of their work.

The original-source evidence library distinguishes journal articles, conference papers, research reports and expert opinions. Reports, translations and later manuscripts describing the same experiment should not be counted as independent replications.

Editorial update: October 25, 2026 · Josh, Aires. This page explains research and its limitations; it is not a diagnosis or a claim that an Aires product prevents or treats disease.